We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
Cap. Flow
+$3.18B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.93B
2
MSFT icon
Microsoft
MSFT
+$556M
3
COR icon
Cencora
COR
+$492M
4
NFLX icon
Netflix
NFLX
+$452M
5
BAC icon
Bank of America
BAC
+$411M

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Consumer Discretionary 12.64%
3 Healthcare 9.35%
4 Financials 8.34%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUB icon
1476
Atlantic Union Bankshares
AUB
$5.98B
$2.51M ﹤0.01%
71,194
+47,001
+194% +$1.6M
CAI
1477
Caris Life Sciences
CAI
$4.42B
$2.51M ﹤0.01%
82,975
+45,102
+119% +$1.44M
EFG icon
1478
iShares MSCI EAFE Growth ETF
EFG
$16.4B
$2.51M ﹤0.01%
+22,040
New +$2.46M
ACLS icon
1479
Axcelis
ACLS
$3.94B
$2.51M ﹤0.01%
+25,684
New +$2.07M
XRAY icon
1480
Dentsply Sirona
XRAY
$2.61B
$2.51M ﹤0.01%
+197,506
New +$2.87M
ENSG icon
1481
The Ensign Group
ENSG
$10.4B
$2.5M ﹤0.01%
14,462
-83,087
-85% -$13.2M
HUM icon
1482
PUT
Humana
HUM
$45.8B
$2.5M ﹤0.01%
+9,600
New +$2.52M
GL icon
1483
Globe Life
GL
$13.5B
$2.5M ﹤0.01%
17,466
-130,214
-88% -$17.6M
VIAV icon
1484
Viavi Solutions
VIAV
$9.41B
$2.5M ﹤0.01%
196,752
-129,443
-40% -$1.42M
EVAC
1485
EQV Ventures Acquisition Corp II
EVAC
$598M
$2.49M ﹤0.01%
+250,000
New +$2.48M
BLD
1486
DELISTED
TopBuild
BLD
$2.48M ﹤0.01%
6,357
+4,848
+321% +$1.94M
GOTU icon
1487
Gaotu Techedu
GOTU
$374M
$2.48M ﹤0.01%
761,712
-26,829
-3% -$97.4K
WIT icon
1488
Wipro
WIT
$18.9B
$2.48M ﹤0.01%
944,058
-4,681,736
-83% -$13.2M
TATT icon
1489
TAT Technologies
TATT
$560M
$2.48M ﹤0.01%
56,339
-24,648
-30% -$874K
VISN
1490
Vistance Networks Inc
VISN
$2.67B
$2.48M ﹤0.01%
160,078
-89,382
-36% -$1.16M
AMBA icon
1491
CALL
Ambarella
AMBA
$2.99B
$2.47M ﹤0.01%
+29,900
New +$2.17M
SRDX
1492
DELISTED
Surmodics
SRDX
$2.46M ﹤0.01%
82,373
+48,105
+140% +$1.61M
J icon
1493
Jacobs Solutions
J
$16B
$2.46M ﹤0.01%
16,389
+12,209
+292% +$1.75M
PTEN icon
1494
Patterson-UTI
PTEN
$3.57B
$2.44M ﹤0.01%
+471,487
New +$2.71M
ACHV icon
1495
Achieve Life Sciences
ACHV
$634M
$2.44M ﹤0.01%
+774,853
New +$2.13M
PAYO icon
1496
Payoneer
PAYO
$2.41B
$2.44M ﹤0.01%
+402,591
New +$2.7M
AZZ icon
1497
AZZ Inc
AZZ
$4.47B
$2.43M ﹤0.01%
+22,295
New +$2.47M
PKX icon
1498
POSCO
PKX
$16.1B
$2.43M ﹤0.01%
+49,345
New +$2.66M
GHRS icon
1499
GH Research
GHRS
$1.9B
$2.42M ﹤0.01%
+169,500
New +$2.37M
MCRB icon
1500
Seres Therapeutics
MCRB
$47M
$2.42M ﹤0.01%
125,600
+34,195
+37% +$546K

Similar funds

Marshall Wace's Q3 2025 Portfolio in Review

As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.

  • Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
  • Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
  • Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
  • Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
  • Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.